Phapros Tbk PT - Asset Resilience Ratio

Latest as of December 2025: 5.12%

Phapros Tbk PT (PEHA) has an Asset Resilience Ratio of 5.12% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Phapros Tbk PT to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rp71.02 Billion

≈ $4.16 Million USD Cash + Short-term Investments

Total Assets

Rp1.39 Trillion

≈ $81.28 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Phapros Tbk PT's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Phapros Tbk PT balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Phapros Tbk PT's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Phapros Tbk PT (PEHA) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rp70.40 Billion	5.08%
Short-term Investments	Rp620.61 Million	0.04%
Total Liquid Assets	Rp71.02 Billion	5.12%

Asset Resilience Insights

Limited Liquidity: Phapros Tbk PT maintains only 5.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Phapros Tbk PT Industry Peers by Asset Resilience Ratio

Compare Phapros Tbk PT's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Phapros Tbk PT (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Phapros Tbk PT.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.08%	Rp70.40 Billion ≈ $4.13 Million	Rp1.39 Trillion ≈ $81.28 Million	+5.05pp
2024-12-31	0.03%	Rp400.00 Million ≈ $23.44K	Rp1.43 Trillion ≈ $83.79 Million	-0.16pp
2023-12-31	0.19%	Rp3.40 Billion ≈ $199.23K	Rp1.77 Trillion ≈ $103.47 Million	+4.47pp
2022-12-31	-4.28%	Rp-77.25 Billion ≈ $-4.53 Million	Rp1.81 Trillion ≈ $105.84 Million	-0.08pp
2021-12-31	-4.20%	Rp-77.15 Billion ≈ $-4.52 Million	Rp1.84 Trillion ≈ $107.73 Million	-2.84pp
2020-12-31	-1.36%	Rp-26.01 Billion ≈ $-1.52 Million	Rp1.92 Trillion ≈ $112.27 Million	-3.89pp
2019-12-31	2.54%	Rp53.18 Billion ≈ $3.12 Million	Rp2.10 Trillion ≈ $122.86 Million	+2.64pp
2018-12-31	-0.11%	Rp-1.97 Billion ≈ $-115.14K	Rp1.87 Trillion ≈ $109.50 Million	-11.18pp
2017-12-31	11.08%	Rp130.25 Billion ≈ $7.63 Million	Rp1.18 Trillion ≈ $68.91 Million	+11.66pp
2013-12-31	-0.59%	Rp-3.76 Billion ≈ $-220.58K	Rp643.09 Billion ≈ $37.68 Million	+0.07pp
2012-12-31	-0.66%	Rp-3.66 Billion ≈ $-214.69K	Rp558.64 Billion ≈ $32.73 Million	+0.19pp
2011-12-31	-0.84%	Rp-3.90 Billion ≈ $-228.29K	Rp462.59 Billion ≈ $27.11 Million	--

pp = percentage points

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$14.18 Million

Rp241.92 Billion IDR

Market Cap Rank

#26235 Global

#583 in Indonesia

Share Price

Rp288.00

Change (1 day)

-2.04%

52-Week Range

Rp214.00 - Rp384.00

All Time High

Rp2996.89